Penumbra Inc logo

Penumbra Inc

$ 181.26 -13.4 (-6.88%) 04:00 PM EST
P/E:
At Loss
P/B:
7.38
Market Cap:
$ 6.87B
Enterprise V:
$ 7.39B
Volume:
256.36K
Avg Vol (2M):
340.42K
Also Trade In:
Volume:
256.36K
Market Cap $:
6.87B
PE Ratio:
At Loss
Avg Vol (2-Month):
340.42K
Enterprise Value $:
7.39B
PB Ratio:
7.38
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.93
Equity-to-Asset 0.73
Debt-to-Equity 0.23
Debt-to-EBITDA -15.25
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.44
Distress
Grey
Safe
Beneish M-Score -1.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 53.85
9-Day RSI 56.09
14-Day RSI 57.68
6-1 Month Momentum % -22.82
12-1 Month Momentum % -36.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.93
Quick Ratio 2.9
Cash Ratio 1.4
Days Inventory 328.26
Days Sales Outstanding 65.31
Days Payable 19.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3

Financials (Next Earnings Date:2022-11-03 Est.)

PEN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:PEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 806.367
EPS (TTM) ($) -0.518
Beta 0.42
Volatility % 52.22
14-Day RSI 57.68
14-Day ATR ($) 7.938444
20-Day SMA ($) 193.568
12-1 Month Momentum % -36.69
52-Week Range ($) 114.865 - 290.36
Shares Outstanding (Mil) 37.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Penumbra Inc Filings

Document Form Filing Date
No Filing Data

Penumbra Inc Analysis

Share your research

Headlines

See More
No news.